Trial intelligence / Profile preview

Prednisolone vs Pregabalin for Post-dural Puncture Headache

NCT04662125Completed

Sponsor
Zagazig University
Start
Dec 2020
Primary completion
Aug 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of prednisolone and pregabalin in post-dural puncture headache (PDPH) (3 arms), sponsored by Zagazig University. Primary endpoint: Pain Intensity of Headache at 72 hours. Started Dec 2020; status: completed.

02

Drugs

prednisolonepregabalin
03

Conditions

post-dural puncture headache (PDPH)

Beyond the preview

Go deeper on NCT04662125.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04662125.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call